Assessing the quality and communicative aspects of patient decision aids for early-stage breast cancer treatment: a systematic review Ruben VromansKim TenfeldeEmiel Krahmer Review Open access 24 July 2019 Pages: 1 - 15
Prognostic and clinicopathological value of PD-L1 expression in primary breast cancer: a meta-analysis Wenfa HuangRan RanHuiping Li Review 29 July 2019 Pages: 17 - 33
Syndecan-1 facilitates breast cancer metastasis to the brain Megan R. SayyadMadhavi PuchalapalliJennifer E. Koblinski Preclinical study 20 July 2019 Pages: 35 - 49
Accuracy and clinical implications of pre-operative breast core needle biopsy diagnoses of fibroepithelial neoplasms and sarcomatoid carcinomas Alisha D. WarePedram ArganiAshley Cimino-Mathews Preclinical study 22 July 2019 Pages: 51 - 56
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients Marzia Del ReIlaria BertoliniRomano Danesi Preclinical study 26 July 2019 Pages: 57 - 62
Plasma cell-free DNA chromosomal instability analysis by low-pass whole-genome sequencing to monitor breast cancer relapse Huanhuan ZhouXiao-Jia WangWen-Ming Cao Preclinical study 30 July 2019 Pages: 63 - 73
PK-M2-mediated metabolic changes in breast cancer cells induced by ionizing radiation Le ZhangJustine BailleulErina Vlashi Preclinical study 01 August 2019 Pages: 75 - 86
Risk of malignancy in papillary neoplasms of the breast Claire LiuRavi SidhuElaine McKevitt Clinical trial 22 July 2019 Pages: 87 - 94
Effects of cyclic adjustment training delivered via a mobile device on psychological resilience, depression, and anxiety in Chinese post-surgical breast cancer patients Kaina ZhouJin LiXiaomei Li Clinical trial 24 July 2019 Pages: 95 - 103
Survival benefit of postoperative radiotherapy for ductal carcinoma in situ after breast-conserving surgery: a Korean population-based cohort study Byoung Hyuck KimByung Kyun KoKi-Tae Hwang Clinical Trial 25 July 2019 Pages: 105 - 113
Can we see what is invisible? The role of MRI in the evaluation and management of patients with pathological nipple discharge Konstantinos ZacharioudakisTheodoros KontoulisDimitri J. Hadjiminas Clinical trial Open access 27 July 2019 Pages: 115 - 120
A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancer Vandana G. AbramsonMafalda OliveiraIan E. Krop Clinical trial 31 July 2019 Pages: 121 - 133
Vaginal CO2 laser for the treatment of vulvovaginal atrophy in women with breast cancer: LAAVA pilot study Antonia PearsonAndrew BookerGavin Marx Clinical trial 03 August 2019 Pages: 135 - 140
Improved survival of older patients with advanced breast cancer due to an increase in systemic treatments: a population-based study Nienke de GlasEsther BastiaannetJohanneke Portielje Epidemiology Open access 19 July 2019 Pages: 141 - 149
Assessing the effectiveness of the National Comprehensive Cancer Network genetic testing guidelines in identifying African American breast cancer patients with deleterious genetic mutations Foluso O. AdemuyiwaPatricia SalyerLaura J. Bierut Epidemiology 19 July 2019 Pages: 151 - 159
National trends of synchronous bilateral breast cancer incidence in the United States Takehiko SakaiEnver OzkurtMehra Golshan Epidemiology 19 July 2019 Pages: 161 - 167
Multiple foci of microinvasion is associated with an increased risk of invasive local recurrence in women with ductal carcinoma in situ treated with breast-conserving surgery Eileen RakovitchRinku SutradharLawrence Paszat Epidemiology 19 July 2019 Pages: 169 - 176
The impact of hospital volume on patient safety indicators following post-mastectomy breast reconstruction in the US Clifford C. SheckterDanielle RochlinArash Momeni Epidemiology 23 July 2019 Pages: 177 - 183
Risk stratification of triple-negative breast cancer with core gene signatures associated with chemoresponse and prognosis Eun-Kyu KimAe Kyung ParkWonshik Han Epidemiology 24 July 2019 Pages: 185 - 197
Risk of breast cancer among women with benign ovarian tumors: a Danish nationwide cohort study Mathilde GottschauAllan JensenSusanne K. Kjær Epidemiology 30 July 2019 Pages: 199 - 205
Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism in Brazilian breast cancer patients: association with susceptibility, clinicopathological features, and interaction with TGFB1 haplotypes Glauco Akelinghton Freire VitielloMarla Karine AmaranteMaria Angelica Ehara Watanabe Epidemiology 30 July 2019 Pages: 207 - 219
The time-varying effect of radiotherapy after breast-conserving surgery for DCIS Eileen RakovitchRinku SutradharLawrence Paszat Epidemiology 31 July 2019 Pages: 221 - 230
The yield of full BRCA1/2 genotyping in Israeli Arab high-risk breast/ovarian cancer patients Rinat Bernstein-MolhoInbal Barnes-KedarYael Goldberg Epidemiology 31 July 2019 Pages: 231 - 237
Risk factors associated with the incidence and time to onset of lapatinib-induced hepatotoxicity Jin Young MoonJi Min HanHye Sun Gwak Epidemiology 01 August 2019 Pages: 239 - 244
In BRCA mutation carriers breast conserving surgery may not be the best choice R. M. TrimboliS. SchiaffinoF. Sardanelli Letter to the Editor 27 July 2019 Pages: 245 - 246
The potential role of neutrophil trogocytosis and G-CSF in the loss of HER2 expression Z. StrizovaJ. Vachtenheim Jr.J. Bartunkova Letter to the Editor 03 August 2019 Pages: 247 - 248
Correction to: Non-contrast MRI for breast screening: preliminary study on detectability of benign and malignant lesions in women with dense breasts Yangyang BuJun XiaJiani Hu Correction 20 August 2019 Pages: 249 - 250
